Eslicarbazepine acetate in the management of refractory bipolar disorder.

  title={Eslicarbazepine acetate in the management of refractory bipolar disorder.},
  author={Kripamoy Nath and Arnab Bhattacharya and Samir Kumar Praharaj},
  journal={Clinical neuropharmacology},
  volume={35 6},
Eslicarbazepine acetate is a novel third-generation antiepileptic related to carbamazepine and oxcarbazepine with a benign adverse effect profile. We report a patient with bipolar mania with intolerance to multiple antimanic drugs, responding to eslicarbazepine without any serious adverse effect. 
Related Discussions
This paper has been referenced on Twitter 1 time. VIEW TWEETS

From This Paper

Topics from this paper.

Similar Papers

Loading similar papers…